Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substance abuse and cognitive functioning in schizophrenia

J Addington1, D Addington

  • 1Department of Psychiatry, University of Calgary, Alberta, Canada.

Journal of Psychiatry & Neuroscience : JPN
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts.

Schizophrenia research·2024
Same author

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Schizophrenia research·2020
Same author

Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

Development and psychopathology·2020
Same author

Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis.

Behavioural and cognitive psychotherapy·2019
Same author

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.

Schizophrenia research·2019
Same author

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

Schizophrenia research·2018
Same journal

Dynamics of thoughts-novel candidate marker for differential-diagnosis of mental disorders?

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Differences in cortical gyrification and fractional amplitude of low-frequency fluctuations between early- and late-onset obsessive-compulsive disorder.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Major depressive disorder is associated with reduced intrinsic connectivity between the bed nucleus of the stria terminalis and ventral striatum.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

The Eph-ephrin system in neuropsychiatric and neurodevelopmental disorders.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Machine learning-based computational validation of the Addictions Neuroclinical Assessment framework in relation to hazardous drinking.

Journal of psychiatry & neuroscience : JPN·2026
See all related articles

Individuals with schizophrenia are more prone to substance abuse, impacting treatment and cognitive function. This study found substance-abusing schizophrenia patients reported lower quality of life but similar cognitive and social functioning compared to non-abusers.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Addiction Medicine

Background:

  • Schizophrenia (SCZ) is frequently comorbid with substance use disorders (SUDs).
  • Substance abuse in SCZ can exacerbate symptoms, impair treatment adherence, and negatively affect cognitive abilities.
  • Understanding the impact of SUDs on functioning in SCZ is crucial for effective clinical management.

Purpose of the Study:

  • To compare social and cognitive functioning, and symptomology between schizophrenia patients with and without substance abuse.
  • To investigate the specific domains of cognitive function affected by comorbid substance abuse in schizophrenia.

Main Methods:

  • A matched, cross-sectional study design was employed.
  • 33 outpatient schizophrenia subjects with substance abuse were matched with 33 non-abusing schizophrenia subjects on sex, age, and education.

Related Experiment Videos

  • Assessments included measures of social functioning, quality of life, verbal ability, attention, executive functioning, and verbal/visual memory.

    • Main Results:

    • Substance-abusing schizophrenia subjects reported a significantly lower quality of life compared to non-abusing subjects.
    • No significant differences were found between the groups in social functioning or cognitive performance across various domains.
    • Potential explanations for the lack of cognitive differences are discussed.

    Conclusions:

    • Comorbid substance abuse in schizophrenia is associated with diminished quality of life.
    • Despite theoretical concerns, substance abuse may not universally impair cognitive functioning in schizophrenia patients when matched for key demographics.
    • Further research is needed to elucidate the complex interplay between schizophrenia, substance abuse, and cognitive outcomes.